Neut-X can be successfully used as diagnostic and prognostic tool in MDS.
暂无分享,去创建一个
U. Germing | G. Kobbe | R. Fenk | R. Haas | N. Gattermann | A. Kuendgen | C. Barthuber | A. Boquoi | J. Strapatsas
[1] A. A. van de Loosdrecht,et al. Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes , 2018, Pathobiology.
[2] L. Saft,et al. Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells. , 2018, Leukemia research.
[3] G. Ossenkoppele,et al. Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias. , 2016, European journal of cancer.
[4] G. Garcia-Manero. CME Information: Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification and management , 2014 .
[5] U. Germing,et al. Myelodysplastic syndromes: diagnosis, prognosis, and treatment. , 2013, Deutsches Arzteblatt international.
[6] M. Cazzola,et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. , 2013, Blood.
[7] Luca Malcovati,et al. Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.
[8] C. Pascutto,et al. Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study , 2012, Haematologica.
[9] U. Germing,et al. Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes. , 2012, Leukemia research.
[10] D. Costa,et al. The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome. , 2012, Leukemia research.
[11] Raviv Raich,et al. Immunophenotypic signatures of benign and dysplastic granulopoiesis by cytomic profiling , 2011, Cytometry. Part B, Clinical cytometry.
[12] Christina Hoffmann,et al. Granularity Index of the SYSMEX XE-5000 hematology analyzer as a replacement for manual microscopy of toxic granulation neutrophils in patients with inflammatory diseases , 2011, Clinical chemistry and laboratory medicine.
[13] M. Uranga,et al. The utility of the Sysmex XE‐2100 analyzer’s NEUT‐X and NEUT‐Y parameters for detecting neutrophil dysplasia in myelodysplastic syndromes , 2010, International journal of laboratory hematology.
[14] H. Deeg,et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. , 2003, Blood.
[15] A. Öst,et al. Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromes. , 1989, Leukemia research.